The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...

By reducing inflammation, the researchers were able to prevent both the buildup of immune cells and the formation of these ...

As we age, our vision undergoes natural changes, including difficulty focusing on near objects (presbyopia) and reduced light ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

A wireless implant helped patients with severe macular degeneration regain usable vision. The results point toward a new ...

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...

The overall dry AMD market size in the US is anticipated to increase, due to the uptake of recently approved therapies, the launch of emerging therapies such as Gildeuretinol (Alkeus Pharmaceuticals), ...

Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...